This
project will improve the diagnosis of nine OIE List A diseases, by
directly addressing Task 2 (Diagnostic tests, new technologies), Priority
thematic
area 8 (1.4). It also addresses the recommendations of the Scientific
Committee on Animal Health and Animal Welfare (SCAHAW). The programme
will focus
on new and emerging technologies, specifically the development, validation
and dissemination of robust, specific and sensitive diagnostic tests
for OIE List A diseases. It will combine the development of improved “front
line” diagnostics, like dip-stick tests, that can be used by veterinarians
in the field with development of robust and simple nucleic acid and
antigen-antibody detection methodologies to be used in local laboratories
and in abattoirs.
In addition, the work programme will develop and evaluate diagnostic
tests for OIE List A diseases based on the most recent advances in real-time
PCR technology and methods to detect nucleic acids without thermocycling.
The project brings together an extended multidisciplinary scientific team.
This combination of partners will result the development of new diagnostic
methods, which will be applicable world-wide, while maintaining solid European
control. Global dissemination of the results is provided by the structure
of the consortium.

The concept is in support of the stated EU ethos of global international
co-operation being encouraged for RTD activities, which deserve
being tackled in a broader trans-boundary context. Success of the
project will
result in improved welfare for animals and reduction of the danger
of large epizooties.
The
outcome will have a positive impact on consumer concerns in Europe.
Because List A diseases permanently threaten the EU, a multinational
and multidisciplinary
research effort is appropriate and will contribute to realise the objectives
of the priority thematic area: policy-orientated research.